Physician profile
Howard Aubert
NPI 1912116989
$9,981.26
in general payments reported to CMS, 2019-2025
33 companies · $259 in 2025
The $259 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,445 · 2020: $440 · 2021: $482 · 2022: $1,379 · 2023: $260 · 2024: $716 · 2025: $259.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,235.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,235.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,208.84 | 2019-2020 | |
| Procept Biorobotics Corporation | $1,245.37 | 2022-2025 | Aquabeam System |
| Axonics, INC. | $338.21 | 2022-2024 | Axonics |
| Boston Scientific Corporation | $333.06 | 2019-2025 | Spaceoar System, General - Erectile Dysfunction, Rezum Generator |
| Coloplast Corp | $298.15 | 2019-2024 | |
| Astellas Pharma US INC | $211.39 | 2019-2023 | Myrbetriq, Veozah |
| Tolmar Pharmaceuticals, INC. | $171.67 | 2019 | |
| Teleflex LLC | $160.51 | 2021-2022 | |
| Neotract INC. | $135.73 | 2019 | |
| Janssen Biotech, INC. | $92.81 | 2021-2024 | Akeega, Erleada, Balversa |
| Abbvie INC. | $91.89 | 2024 | |
| Endo Pharmaceuticals INC. | $89.97 | 2019-2020 | |
| Femselect INC. | $88.45 | 2023 | Enplace |
| Myovant Sciences INC. | $61.44 | 2021-2022 | |
| Endo USA, INC. | $42.05 | 2025 | Xiaflex |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $37.74 | 2024-2025 | Quviviq, Quviviq |
| Allergan, INC. | $35.68 | 2021 | |
| Medtronic, INC. | $35.62 | 2023 | Interstim |
| Valencia Technologies Corporation | $31.02 | 2025 | Ecoin Device Kit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $25.57 | 2024 | Lifevest |
| Tolmar, INC. | $23.22 | 2025 | Eligard, Jatenzo |
| Bayer Healthcare Pharmaceuticals INC. | $22.11 | 2021 | |
| Shield Therapeutics INC | $22.06 | 2024 | |
| Agiliti Surgical, INC. | $21.66 | 2025 | Koelis Trinity Mri/US Fusion, Sonablate Hifu, Quanta System Fiber Dust Tfl Laser |
| Myriad Women'S Health, INC. | $21.18 | 2023 | Myrisk |
| Medtronic USA, INC. | $19.85 | 2019 | |
| Biotissue Holdings INC. | $19.22 | 2022 | |
| Aspira Women'S Health INC | $18.11 | 2023 | Ova1 |
| Merck Sharp & Dohme LLC | $18.05 | 2022 | |
| Acerus Pharmaceuticals Corporation | $17.38 | 2020 | |
| Pfizer INC. | $17.11 | 2021 | |
| Millicent US INC | $14.55 | 2025 | Femring, Intrarosa |
| Laborie Medical Technologies Corp. | $11.59 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Howard Aubert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.